Andrew Berens
Stock Analyst at Leerink Partners
Total Price Targets
14
Stocks Covered
9
Sectors
Healthcare
Most Recent
Dec 17, 2025
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Andrew Berens
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| REGN | Regeneron Pharmaceuticals, Inc. | $873.00 | $703.72 | +24.1% | 3 | Dec 17, 2025 |
| ZYME | Zymeworks Inc. | $37.00 | $26.93 | +37.4% | 3 | Nov 17, 2025 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $2.00 | $4.09 | -51.1% | 1 | Nov 11, 2025 |
| CMPX | Compass Therapeutics, Inc. | $6.00 | $1.97 | +205.3% | 1 | Apr 2, 2025 |
| LLY | Eli Lilly and Company | $950.00 | $961.67 | -1.2% | 2 | Jan 17, 2025 |
| IDYA | IDEAYA Biosciences, Inc. | $27.00 | $28.27 | -4.5% | 1 | Nov 5, 2024 |
| GILD | Gilead Sciences, Inc. | $96.00 | $132.04 | -27.3% | 1 | Oct 21, 2024 |
| AGIO | Agios Pharmaceuticals, Inc. | $56.00 | $28.15 | +98.9% | 1 | Sep 27, 2024 |
| AZN | AstraZeneca PLC | $158.00 | $185.21 | -14.7% | 1 | Jul 12, 2023 |
Recent Activity
- Dec 17, 2025— Set$873.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Nov 17, 2025— Set$37.00price target onZYME(Zymeworks Inc.)
- Nov 11, 2025— Set$2.00price target onZNTL(Zentalis Pharmaceuticals, Inc.)
- Apr 2, 2025— Set$6.00price target onCMPX(Compass Therapeutics, Inc.)
- Jan 17, 2025— Set$950.00price target onLLY(Eli Lilly and Company)
- Nov 21, 2024— Set$26.00price target onZYME(Zymeworks Inc.)
- Nov 5, 2024— Set$27.00price target onIDYA(IDEAYA Biosciences, Inc.)
- Nov 1, 2024— Set$880.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
- Oct 21, 2024— Set$96.00price target onGILD(Gilead Sciences, Inc.)
- Oct 14, 2024— Set$990.00price target onLLY(Eli Lilly and Company)
- Sep 27, 2024— Set$56.00price target onAGIO(Agios Pharmaceuticals, Inc.)
- Sep 18, 2024— Set$10.00price target onZYME(Zymeworks Inc.)
- Jul 12, 2023— Set$158.00price target onAZN(AstraZeneca PLC)
- Mar 27, 2023— Set$976.00price target onREGN(Regeneron Pharmaceuticals, Inc.)
Frequently Asked Questions
Who is Andrew Berens?
Andrew Berens is a stock analyst at Leerink Partners covering 9 stocks primarily in Healthcare. They have issued 14 price targets since Mar 27, 2023.
What stocks does Andrew Berens cover?
Andrew Berens currently covers 9 stocks, including REGN, ZYME, LLY, ZNTL, CMPX.
What is Andrew Berens's latest price target?
Andrew Berens's most recent price target was $873.00 on REGN (Regeneron Pharmaceuticals, Inc.), set on Dec 17, 2025.
What is Andrew Berens's highest price target?
Andrew Berens's highest issued price target is $990.00 on LLY, set on Oct 14, 2024.
More Analysts at Leerink Partners
Coverage based on publicly published price targets. Not investment advice.